The new patterns of nephrolithiasis: What has been changing in the last millennium?
https://doi.org/10.4081/aiua.2021.2.195
Accepted: May 17, 2021
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Nephrolithiasis has been increasing over the last millennium. Although early epidemiologic studies have shown that kidney stones were two to three times more frequent in males than in females, recent reports have suggested that this rate is decreasing. In parallel a dramatic increase of nephrolithiasis has also been observed among children and adolescents. Furthermore, epidemiologic studies have shown a strong association between metabolic syndrome (Mets) traits and kidney stone disease. Patients with hypertension have a higher risk of stone formation and stone formers are predisposed to develop hypertension compared to the general population. An incidence of nephrolithiasis greater than 75% has been shown in overweight and obese patients compared to those of normal weight. It has also been reported that a previous diagnosis of diabetes mellitus increases the risk of future nephrolithiasis. Additionally, an association between metabolic syndrome and uric acid stone formation has been clearly recognized. Furthermore, 24-h urinary metabolic abnormalities have been decreasing among patients with nephrolithiasis over the last decades. Finally, nephrolithiasis could cause chronic kidney disease (CKD) and end stage renal disease (ESRD), especially in women and overweight patients. According to these observations, a better understanding of these new features among stone former patients may be required. Hence, the recognition and the correction of metabolic disorders could help not only to reduce the primary disease, but also stone recurrence.
Lieske JC, Pena de la Vega, Slezak JM, et al. Renal epidemiology in Rochester, Minnesota. Kidney Int. 2006; 69:760-764. DOI: https://doi.org/10.1038/sj.ki.5000150
Pearle MS, Calhoun EA, Curhan GC. Urologic diseases in America project: urolithiasis. J Urol. 2005; 173:848-857. DOI: https://doi.org/10.1097/01.ju.0000152082.14384.d7
Strope SA, Wolf JS jr and Hollenback BK. Changes in gender distribution urinary stone disease. Urology. 2010; 75:543-546. DOI: https://doi.org/10.1016/j.urology.2009.08.007
Scales C Jr, Curtis LH, Norris RD, et al. Changing in gender prevalence of stone disease. J Urol. 2007; 177:979-982. DOI: https://doi.org/10.1016/j.juro.2006.10.069
Sas DJ, Hulsey TC, Shataf IF, et al. Increasing incidence of kidney stones in children evaluated in the emergency department. J Pediatr. 2010; 157:132-137. DOI: https://doi.org/10.1016/j.jpeds.2010.02.004
Wong Y, Cook P, Roderick P et al. Metabolic syndrome and kidney stone disease: a systematic review of literature. J Endourol. 2016; 30:246-253. DOI: https://doi.org/10.1089/end.2015.0567
Gorbachinsky I, Apikar H, Assimos DG. Metabolic syndrome and urologic disease. Rev Urol. 2010; 12e-157-e158.
West B, Luke A, Durazo-Arvizu RA et al. Metabolic syndrome and self-reported history of kidney stones: the national Health and Nutritional Examination Survey (NAHNES III) 1988-1994. Am J Kidney Dis. 2008; 51:741-747. DOI: https://doi.org/10.1053/j.ajkd.2007.12.030
Khjimoto Y, Sasaki Y, Iguchi M, et al. Association of metabolic syndrome traits and severity of kidney stones: results of nationwide survey on urolithiasis in Japan. Am J Kidney Dis. 2013; 61:923-929. DOI: https://doi.org/10.1053/j.ajkd.2012.12.028
Boyd C, Wood K, Whitaker D et al. The influence of metabolic syndrome and its components on the development of nephrolithiasis. As J Urol. 2088; 5:215-222. DOI: https://doi.org/10.1016/j.ajur.2018.06.002
Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005; 293:455-462. DOI: https://doi.org/10.1001/jama.293.4.455
Inci M, Demirtas A, Sarli B, et al. Association between body mass index, lipid profiles, and types of urinary stones. Ren Fail. 2012; 34:1140-1143. DOI: https://doi.org/10.3109/0886022X.2012.713298
Cupisti A, Meola M, D’Alessandro C, et al. Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomed Pharmacother. 2007; 61:86-90. DOI: https://doi.org/10.1016/j.biopha.2006.09.012
Sorensen MD, Chi T, Shara NM, et al. Activity, energy intake, obesity, and the risk of incident kidney stones in post-menopausal women: a report from the Women’s Health Initiative. J Am Soc Nephrol. 2014; 25:362-369. DOI: https://doi.org/10.1681/ASN.2013050548
Kim JH, Doo SW, Yang WJ, et al. The relationship between urinary stone components and visceral adipose tissue using computed tomography-based fat delineation. Urology. 2014; 84:27-31. DOI: https://doi.org/10.1016/j.urology.2014.01.026
Nam IC. Association of non-alcoholic fatty liver disease with renal stone disease detected on computed tomography. Eur J Radiol Open. 2016; 3:195-199. DOI: https://doi.org/10.1016/j.ejro.2016.07.004
Trinchieri A, Croppi E, Montanari E. Obesity and urolithiasis: evidence of regional influences. Urolithiasis. 2017; 45:271-278. DOI: https://doi.org/10.1007/s00240-016-0908-3
Maalouf NM, Cameron MA, Moe OW, et al. Low urinary pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol. 2007; 2:883-888. DOI: https://doi.org/10.2215/CJN.00670207
Chou YH, Su CM, Liu CC. Difference in urinary stone components between obese and non-obese patients. Urol Res 2011; 39:283-287. DOI: https://doi.org/10.1007/s00240-010-0344-8
Taylor EN, Stampfer MJ, Curhan CG. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005; 68:1230-1235. DOI: https://doi.org/10.1111/j.1523-1755.2005.00516.x
Eisner BH, Porten SP, Bechis SK, et al. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol. 2010; 183:2244-2248. DOI: https://doi.org/10.1016/j.juro.2010.02.007
Sakhaee K, Adams- Huet B, Moe OW, et al. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int. 2002; 62:971-979. DOI: https://doi.org/10.1046/j.1523-1755.2002.00508.x
Weinberg AE, Patel CJ, Chertow GM et al. Diabetic severity and risk of kidney stone disease. Eur Urol. 2014; 65:242-247. DOI: https://doi.org/10.1016/j.eururo.2013.03.026
Torricelli FC, De S, Gebreselassie SK, et al. Dyslipidemia and kidney stone risk. J Urol. 2014; 191:667-672. DOI: https://doi.org/10.1016/j.juro.2013.09.022
Masterson JH, Woo JR, Chang DC, et al. Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis 2015; 43:49-53. DOI: https://doi.org/10.1007/s00240-014-0719-3
Borghi L, Meschi T, Guerra A, et al. Essential hypertension in stone disease. Kidney Int. 1999; 55:2397-2406. DOI: https://doi.org/10.1046/j.1523-1755.1999.00483.x
Kittanamongkolchai W, Mara KC, Mehta RA, et al. Risk of hypertension among first time symptomatic kidney stone formers. Clin J Am Soc Nephrol. 2017; 12:476- 482. DOI: https://doi.org/10.2215/CJN.06600616
Mente A, Honey RJ, Mc Laughlin JM, et al. High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease. J Am Soc Nephrol. 2006; 17:2567-2575. DOI: https://doi.org/10.1681/ASN.2005121309
Losito A, Nunzi EG, Covarelli C, et al. Increased acid excretion in kidney stone formers with essential hypertension. Nephrol Dial Transplant. 2009; 24:137-141. DOI: https://doi.org/10.1093/ndt/gfn468
Reiner AP, Kahn A, Eisner BH, et al. Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol. 2011; 185:920-925. DOI: https://doi.org/10.1016/j.juro.2010.10.086
Rule AD, Roger VL, Melton LJ, et al. Kidney stones associate with increased risk for myocardial infarction. AM J Soc Nephrol. 2010; 21:1641-1644. DOI: https://doi.org/10.1681/ASN.2010030253
Aydin H, Yencilek F, Erihan IB, et al. Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis. Urol Res. 2011; 38:451-458. DOI: https://doi.org/10.1007/s00240-011-0383-9
Hamano S, Nakatsu H, Suzuki N, et al. Kidney stone disease and risk factors for coronary stone disease. Int J Urol. 2005; 12:859-863. DOI: https://doi.org/10.1111/j.1442-2042.2005.01160.x
Patel ND, Ward RD, Calle J, et al. Vascular disease and kidney stones: abdominal aortic calcifications are associated with low urine pH and hypocitraturia. J Endourol. 2017; 31:956-961. DOI: https://doi.org/10.1089/end.2017.0350
Scales C Jr, Smith AC, Hanley JM, et al Prevalence of kidney stones in the United States. Eur Urol. 2012; 62:160-165. DOI: https://doi.org/10.1016/j.eururo.2012.03.052
Tundo G, Khaleel S, Vernon MP Jr. Gender equivalence in the prevalence of nephrolithiasis among younger than 50 years in the United States. J Urol. 2018; 20:1273-1277. DOI: https://doi.org/10.1016/j.juro.2018.07.048
Cicerello E, Mangano MS, Cova GD, et al. Changing in gender prevalence of nephrolithiasis. Urologia. 2021; 88:90-93. DOI: https://doi.org/10.1177/0391560320966206
Moses RA, Pais VM, Ursiny M, et al. Changes in stone composition over two decades: evaluation of over 10.000 stone analysis. Urolithiasis. 2015; 43:135-139. DOI: https://doi.org/10.1007/s00240-015-0756-6
Abate N, Chandalia M, Cabo-Chan AV Jr, et al. The metabolic syndrome and and uric acid nephrolithiasis: novel feature renal of manifestation of insulin resistance. Kidney Int. 2004; 65:386-392. DOI: https://doi.org/10.1111/j.1523-1755.2004.00386.x
Reinstatler L, Khaleel, Pais VM Jr. Association of pregnancy with stone formation among women in the United States: a NAHNES analysis 2007 to 2012. J Urol. 2017:198:389-393. DOI: https://doi.org/10.1016/j.juro.2017.02.3233
Lieske JC, Rule AD, Kramberk AE, et al. Stone composition as a function of age and sex. Clin J Am Soc Nephrol. 2014; 9:2141-2146. DOI: https://doi.org/10.2215/CJN.05660614
Routh JC, Graham DA, Nelson CP. Epidemiological trends in pediatrics urolithiasis at United States freestanding pediatrics hospitals. J Urol. 2010; 184:1100-1104. DOI: https://doi.org/10.1016/j.juro.2010.05.018
Dwyer ME, Krambeck AE, et al. Temporal trends in incidence of kidney stones among children: a 25-year population based study. J Urol. 2012; 188:247-252. DOI: https://doi.org/10.1016/j.juro.2012.03.021
Novak TE, Lakshmanan Y, Trock BJ, et al. Sex prevalence of pediatric kidney stone disease in United States: an epidemiological investigation. Urology. 2009; 74:104-107. DOI: https://doi.org/10.1016/j.urology.2008.12.079
Bush NC, Xu L, Brown BJ, et al. Hospitalization for pediatric stone disease in United States, 2002-2007. J Urol. 2010; 183:1151-1156. DOI: https://doi.org/10.1016/j.juro.2009.11.057
Ogden CL, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012; 307:483-490. DOI: https://doi.org/10.1001/jama.2012.40
Vos MB, Kimmons JE, Gillespie C, et al. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med. 2008;10:160-177.
US Institute of Medicine. Strategies to reduce sodium intake in the United States. National Academic of Sciences. 2010. Available from: hhp:// www.iom.edu/Reports /2010/Strategies-to-Reduce -Sodium Intake-in-the United-States/Report-Brief-Strategies-to-Reduce-Sodium-Intake-in-the-United-States.aspx.
Kant AK, Graubard BI. Contributors of water intake in US children and adolescents: associations with dietary and meal characteristics-National Healthand Nutrition Examination Survey 2005-2006. Am J Clin Nutr. 2010; 92:887-896. DOI: https://doi.org/10.3945/ajcn.2010.29708
El-Zoghby ZM, Lieske JC, Foley RN, et al. Urolithiasis and the risk of ERSD. Clin J Am Soc Nephrol. 2012; 7:1409-1415. DOI: https://doi.org/10.2215/CJN.03210312
Alexander RT, Hemmelgarn BR, Wiebe Net al. Kidney stones and kidney function loss: a cohort study. BMJ. 2012; 345:e5287. DOI: https://doi.org/10.1136/bmj.e5287
Shoag J, Halpern J, Goldfarb DS, et al. Risk of chronic and stage kidney disease in patients with nephrolithiasis. J Urol. 2014;192:1440-1445. DOI: https://doi.org/10.1016/j.juro.2014.05.117
Gambaro G, Croppi E, Bushinnsky D, et al. The risk of chronic kidney disease associated with urolithiasis and its urological treatment: a review. J Urol. 2017; 198:268-273. DOI: https://doi.org/10.1016/j.juro.2016.12.135
Cicerello E, Mangano MS, Cova GD, Ciaccia M. Changing pattern in nephrolithiasic patients: our experience. Eur Urol Suppl. 2019; 18:e2073-e-2074, DOI: https://doi.org/10.1016/S1569-9056(19)33053-2
Abu-Ghanem Y, Shvero A, Kleinman N, et al. 24-h urine metabolic profile: is necessary in all kidney stone formers? Int Urol Nephrol. 2018; 50:1243-247. DOI: https://doi.org/10.1007/s11255-018-1902-1
Cicerello E, Mangano MS, Cova GD, et al. Metabolic evaluation in patients with infected nephrolithiasis: is it necessary? Arch Ital Urol. 2014:86:257-269. DOI: https://doi.org/10.4081/aiua.2014.4.257
Perletti G, Magri V, Ferraro PM, Montanari E, Trinchieri A. Influence of dietary energy intake on nephrolithiasis - A metaanalysis of observational studies. Arch Ital Urol Androl. 2020;92:30-33 DOI: https://doi.org/10.4081/aiua.2020.1.30
Ford ES, Kol HW III, Mokdad AH, et al. Sedentary behavior, physical activity, and the metabolic syndrome amomg U.S. adults. Ob Res. 2005; 3:608-614. DOI: https://doi.org/10.1038/oby.2005.65
Prezioso D, Strazzullo P, Lotti T, et al. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Arch Ital Urol Androl. 2015; 87:105-120. DOI: https://doi.org/10.4081/aiua.2015.2.105
Wagh A, Stone NJ. Treatment of metabolic syndrome. Exp Rev Cardiov Ther. 2008; 2:213-228. DOI: https://doi.org/10.1586/14779072.2.2.213
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
